Mga Industriya

• Reset all ×
• Pangangalaga sa Kalusugan & Mga Agham sa Buhay ×

Showing 21–30 ng mga 134 results

Sort by popularity Sort by average rating Sort by latest Sort by price: low to high Sort by price: high to low

• 

  Global Molecular Diagnostic Market

  The global molecular diagnostic market is poised to grow by US$ 5,945 milyon sa panahon ng 2021-2027, umuusad sa isang CAGR ng 8.9% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix.

  USD 5
• 

  Chemiluminescence Immunoassay (CLIA) Market in China

  A statistic by StrategyHelix indicates that the chemiluminescence immunoassay (CLIA) market in China is expected to increase by US$ 7,883 milyon mula sa 2021 sa 2027, garnering a CAGR of 17.4% sa panahon ng pagtataya.

  USD 15
• 

  Point of Care Testing (POCT) Market in China

  The point of care testing (POCT) market in China was around 1,855 million USD in 2020, reached 2,235 million USD in 2021 (an increase of 20.5% year-on-year), ayon sa StrategyHelix’ analysis.

  USD 15
• 

  Global Point of Care Testing (POCT) Market

  The global point of care testing (POCT) market was around 27 billion USD in 2020, reached 30 billion USD in 2021 (an increase of 9.4% year-on-year), ayon sa StrategyHelix’ analysis.

  USD 15
• 

  In vitro diagnostics (IVD) Market in China

  A statistic by StrategyHelix indicates that the in vitro diagnostics (IVD) market in China is anticipated to expand positively at a CAGR of 15.6% sa panahon ng pagtataya (2021-2027).

  USD 15
• 

  Global In vitro diagnostics (IVD) Market

  A statistic by StrategyHelix indicates that the global in vitro diagnostics (IVD) market is set to grow at a healthy compound annual growth rate (CAGR) ng mga 7% sa susunod na limang taon.

  USD 20
• 

  Assisted Reproduction Market in China

  The assisted reproduction market in China is set to increase by US$ 9,271 milyon mula sa 2021 sa 2027, representing a compound annual growth rate (CAGR) ng mga 14.2% sa panahon ng pagtataya.

  USD 5
• 

  Drugs for Helicobacter Pylori Infection Market in China

  The drugs for helicobacter pylori infection market in China is set to increase by US$ 5,855 milyon mula sa 2021 sa 2027, representing a compound annual growth rate (CAGR) ng mga 14.2% sa panahon ng pagtataya.

  USD 5
• 

  Inhalation Preparations Market in China

  The inhalation preparations market in China is poised to grow by US$ 3,951 milyon sa panahon ng 2021-2027, umuusad sa isang CAGR ng 12.8% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix.

  USD 5
• 

  Drug for Gastrointestinal Diseases Market in China

  Ayon sa StrategyHelix, the drug for gastrointestinal diseases market in China is expected to increase by US$ 4,900 milyon sa panahon ng 2021-2027, expanding at a CAGR of 6.7% sa panahon ng pagtataya.

  USD 5